Advertisement
Screener

AVITA Medical, Inc. (AVHHL) Research and Development Expense

2.8 / 5 stars · 68/120 Roast Me

AVITA Medical, Inc. Research and Development Expense

AVITA Medical, Inc. (AVHHL) reported Research and Development Expense of $5.08 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.

Financial Statements › Expense Statement › Operating Expenses

us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-06

  • AVITA Medical, Inc. research and development expense for the quarter ending 2026-06-30 was $5.08M, a 0.76% decline year-over-year.
  • AVITA Medical, Inc. research and development expense for the quarter ending 2026-03-31 was $5.63M, a 10.42% decline year-over-year.
  • AVITA Medical, Inc. research and development expense for the quarter ending 2025-12-31 was $5.69M, a 17.34% increase year-over-year.
  • AVITA Medical, Inc. research and development expense for the quarter ending 2025-09-30 was $3.75M, a 30.95% decline year-over-year.
  • AVITA Medical, Inc. research and development expense for fiscal 2025 was $20.84M, a 2.35% increase from fiscal 2024.
  • AVITA Medical, Inc. research and development expense for fiscal 2024 was $20.36M, a 2.21% decline from fiscal 2023.
  • AVITA Medical, Inc. research and development expense for fiscal 2023 was $20.82M, a 50.26% increase from fiscal 2022.
  • AVITA Medical, Inc. research and development expense for fiscal 2022 was $13.86M.
Period endResearch and Development Expense 3 monthResearch and Development Expense 3 month as first filedResearch and Development Expense 6 monthResearch and Development Expense 9 monthResearch and Development Expense 12 monthResearch and Development Expense 12 month as first filed
2026-06-30$5.08M
10-Q · filed 2026-08-06
$10.71M
10-Q · filed 2026-08-06
$16.40M
derived: sum of 3 quarters · filed 2026-08-06
$20.15M
derived: sum of 4 quarters · filed 2026-08-06
2026-03-31$5.63M
10-Q · filed 2026-05-14
$11.32M
derived: sum of 2 quarters · filed 2026-05-14
$15.07M
derived: sum of 3 quarters · filed 2026-05-14
$20.18M
derived: sum of 4 quarters · filed 2026-08-06
2025-12-31$5.69M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12
$9.44M
derived: sum of 2 quarters · filed 2026-02-12
$14.56M
derived: sum of 3 quarters · filed 2026-08-06
$20.84M
10-K · filed 2026-02-12
2025-09-30$3.75M
10-Q · filed 2025-11-06
$8.87M
derived: sum of 2 quarters · filed 2026-08-06
$15.15M
10-Q · filed 2025-11-06
$20.00M
derived: sum of 4 quarters · filed 2026-08-06
2025-06-30$5.12M
10-Q · filed 2026-08-06
$11.40M
10-Q · filed 2026-08-06
$16.25M
derived: sum of 3 quarters · filed 2026-08-06
$21.68M
derived: sum of 4 quarters · filed 2026-08-06
2025-03-31$6.28M
10-Q · filed 2026-05-14
$11.13M
derived: sum of 2 quarters · filed 2026-05-14
$16.56M
derived: sum of 3 quarters · filed 2026-05-14
$21.45M
derived: sum of 4 quarters · filed 2026-05-14
2024-12-31$4.85M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12
$10.28M
derived: sum of 2 quarters · filed 2026-02-12
$15.16M
derived: sum of 3 quarters · filed 2026-02-12
$20.36M
10-K · filed 2026-02-12
2024-09-30$5.43M
10-Q · filed 2025-11-06
$10.31M
derived: sum of 2 quarters · filed 2025-11-06
$15.51M
10-Q · filed 2025-11-06
$22.27M
derived: sum of 4 quarters · filed 2025-11-06
2024-06-30$4.89M
10-Q · filed 2025-08-08
$10.08M
10-Q · filed 2025-08-08
$16.85M
derived: sum of 3 quarters · filed 2025-08-08
$21.24M
derived: sum of 4 quarters · filed 2025-08-08
2024-03-31$5.19M
10-Q · filed 2025-05-08
$11.96M
derived: sum of 2 quarters · filed 2025-05-08
$16.35M
derived: sum of 3 quarters · filed 2025-05-08
$21.43M
derived: sum of 4 quarters · filed 2025-05-08
2023-12-31$6.76M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13
$11.16M
derived: sum of 2 quarters · filed 2025-02-13
$16.23M
derived: sum of 3 quarters · filed 2025-02-13
$20.82M
10-K · filed 2025-02-13
2023-09-30$4.39M
10-Q · filed 2024-11-07
$9.47M
derived: sum of 2 quarters · filed 2024-11-07
$14.06M
10-Q · filed 2024-11-07
$17.43M
derived: sum of 4 quarters · filed 2024-11-07
2023-06-30$5.08M
10-Q · filed 2024-08-08
$9.66M
10-Q · filed 2024-08-08
$13.04M
derived: sum of 3 quarters · filed 2024-08-08
$16.84M
derived: sum of 4 quarters · filed 2024-08-08
2023-03-31$4.59M
10-Q · filed 2024-05-13
$7.96M
derived: sum of 2 quarters · filed 2024-05-13
$11.76M
derived: sum of 3 quarters · filed 2024-05-13
$14.82M
derived: sum of 4 quarters · filed 2024-05-13
2022-12-31$3.38M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22
$7.18M
derived: sum of 2 quarters · filed 2024-02-22
$10.24M
derived: sum of 3 quarters · filed 2024-02-22
$13.86M
10-K · filed 2024-02-22
2022-09-30$3.80M
10-Q · filed 2023-11-09
$6.86M
derived: sum of 2 quarters · filed 2023-11-09
$10.48M
10-Q · filed 2023-11-09
$14.68M
derived: sum of 4 quarters · filed 2023-11-09
2022-06-30$3.06M
10-Q · filed 2023-08-10
$6.68M
10-Q · filed 2023-08-10
$10.88M
derived: sum of 3 quarters · filed 2023-08-10
$14.27M
derived: sum of 4 quarters · filed 2023-08-10
2022-03-31$3.62M
10-Q · filed 2023-05-11
$7.82M
derived: sum of 2 quarters · filed 2023-05-11
$11.21M
derived: sum of 3 quarters · filed 2023-05-11
$15.18M
derived: sum of 4 quarters · filed 2023-05-11
2021-12-31$4.20M
derived: 10-K 6 month − 10-Q 3 month · filed 2023-02-23
$7.59M
10-K · filed 2023-02-23
$11.56M
derived: sum of 3 quarters · filed 2023-02-23
$15.67M
derived: sum of 4 quarters · filed 2023-02-23
2021-09-30$3.39M
10-Q · filed 2022-11-10
$7.36M
derived: sum of 2 quarters · filed 2022-11-10
$11.47M
10-Q · filed 2022-11-10
$14.83M
derived: sum of 4 quarters · filed 2022-11-10
2021-06-30$3.97M
10-Q · filed 2022-08-11
$8.08M
10-Q · filed 2022-08-11
$11.44M
derived: sum of 3 quarters · filed 2022-08-11
$14.82M
10-K · filed 2023-02-23
2021-03-31$4.11M
10-Q · filed 2022-05-12
$7.47M
derived: sum of 2 quarters · filed 2022-05-12
$10.84M
10-Q · filed 2021-05-13
$13.38M
derived: sum of 4 quarters · filed 2022-05-12
2020-12-31$3.36M
10-K · filed 2021-08-26
$6.74M
10-KT · filed 2022-02-28
$9.27M
derived: sum of 3 quarters · filed 2021-11-08
$11.77M
derived: sum of 4 quarters · filed 2021-11-08
2020-09-30$3.37M
10-Q · filed 2021-11-08
$3.20M
10-Q · filed 2020-11-10
$5.91M
derived: sum of 2 quarters · filed 2021-11-08
$8.41M
derived: sum of 3 quarters · filed 2021-11-08
$10.72M
derived: sum of 4 quarters · filed 2021-11-08
2020-06-30$2.54M
10-K · filed 2021-08-26
$2.33M
10-K · filed 2020-08-27
$5.03M
derived: sum of 2 quarters · filed 2021-08-26
$7.34M
derived: sum of 3 quarters · filed 2021-08-26
$9.16M
10-KT · filed 2022-02-28
$8.46M
10-K · filed 2020-08-27
2020-03-31$2.50M
10-K · filed 2021-08-26
$2.30M
10-K · filed 2020-08-27
$4.81M
derived: sum of 2 quarters · filed 2021-08-26
$6.63M
10-Q · filed 2021-05-13
$8.70M
derived: sum of 4 quarters · filed 2021-08-26
2019-12-31$2.31M
10-K · filed 2021-08-26
$2.19M
10-K · filed 2020-08-27
$4.13M
10-Q · filed 2021-02-16
$6.20M
derived: sum of 3 quarters · filed 2021-08-26
$8.01M
derived: sum of 4 quarters · filed 2021-08-26
2019-09-30$1.82M
10-K · filed 2021-08-26
$1.64M
10-K · filed 2020-08-27
$3.89M
derived: sum of 2 quarters · filed 2021-08-26
$5.70M
derived: sum of 3 quarters · filed 2021-08-26
$7.72M
derived: sum of 4 quarters · filed 2021-08-26
2019-06-30$2.07M
10-K · filed 2020-08-27
$3.88M
derived: sum of 2 quarters · filed 2020-08-27
$5.90M
derived: sum of 3 quarters · filed 2020-08-27
$8.00M
10-K · filed 2021-08-26
$7.87M
10-K · filed 2020-08-27
2019-03-31$1.81M
10-K · filed 2020-08-27
$3.83M
derived: sum of 2 quarters · filed 2020-08-27
$5.80M
derived: sum of 3 quarters · filed 2020-08-27
2018-12-31$2.02M
10-K · filed 2020-08-27
$3.99M
derived: sum of 2 quarters · filed 2020-08-27
2018-09-30$1.97M
10-K · filed 2020-08-27
2018-06-30$6.26M
10-K · filed 2020-08-27